Cannabis Companies Demonstrate the Diverse Nature of the Global Marijuana Market

NetworkNewsWire Editorial Coverage: The cannabidiol market is large and diverse; just a few years ago, it was rather small but by 2015, consumer sales had reached $202 million, according to the CBD Report published by The Hemp Business Journal. Cannabidiol sales are expected to grow to over $2 billion by 2020. The dollar amounts and projections may seem impressive, but they don’t tell the full story, as market demand is being fueled by an increasing number of applications. Medicinal marijuana is used to treat pain and inflammation, nausea, anxiety and diseases such as epilepsy and glaucoma. The medical community has also explored its cardiovascular health benefits and potential to reduce the incidence of diabetes, help people with Alzheimer’s disease and treat cancer. ChineseInvestors.com, Inc. (CIIX) (CIIX Profile) has added cannabis-based skincare products to the mix, as well as a Yelp-style app where products can be reviewed and discussed. It’s joined in the space by companies such as CV Sciences, Inc. (CVSI), Medical Marijuana, Inc. (MJNA), Terra Tech Corp. (TRTC) and MassRoots, Inc. (MSRT).

ChineseInvestors.com, Inc. (CIIX) is staking its position in the market with several product lines, including hemp-infused skin care products. Cannabis is known to have anti-inflammatory and antioxidant properties. The company noted the benefits in this area in an August 2017 press release (http://nnw.fm/z9WPp). They include improvements to skin complexion, thanks to the omega-3 and omega-6 fatty acids present in hemp seed oil. The fatty acids help keep skin moist and stimulate collagen production, helping skin to become firmer. In fact, the human endocannabinoid system includes cannabinoid receptors in the skin.

A recent press release (http://nnw.fm/Tb3Bi) highlights the scope of the company’s hemp-infused product line. CIIX’s wholly owned enterprise, CBD Biotechnology Co. Ltd., has completed the record filing process with the China FDA for the CBD Magic Hemp Series, a line of skin moisturizer, primer and peptide collagen solutions. These cannabidiol-infused products employ the antioxidant and anti-inflammatory benefits of CBD. The ability to sell these products is good news for investors.

Alan Klitenic, Director of Investor Relations for CIIX, was recently featured in an interview with SmallCapVoice.com (http://nnw.fm/flQB8) to discuss CIIX’s hemp-infused skin care line, as well as other company achievements.

“…We have manufactured this product: CBD Infused skin care products line with a design patent. This is a real milestone for us at ChineseInvestors.com. We are going to spend money and promote our CBD Hemp Oil and CBD infused skin care products in China going forward from now and thru 2018.” He also noted that the company is ready to start building distribution channels and begin retail sales, online commerce, social media, and direct marketing initiatives to maximize revenue and the value for shareholders.

Fully aware of the demand for medical cannabis, CIIX has worked to improve the user experience as well. It has developed an investing process, known as the ChineseInvestors Method, and introduced various web-based tools to disseminate market information to investors. That puts investors on the front lines of China’s $30 billion per year skin care product industry.

The company also developed and launched a Chinese-language social media app, approved for download via the Apple App Store. It enables users to view, discuss, and write reviews on cannabis strains and marijuana dispensaries. People can use the application’s maps to find retailers, view business summary reports and see product recommendations. Social media isn’t CIIX’s only strategy, as a recent partnership with the digital agency Launch Haus LLC has spawned a marketing campaign aimed at expanding CIIX’s direct-to-consumer e-commerce business. It also appointed Keevin Gillespie as acting president of ChineseHelpOil.com, Inc., a wholly-owned subsidiary of CIIX, to brand and promote the OptHemp health product line.

As active as the company has been in the cannabis space, it is not the only mover in a fast-growing and diversifying market.

Another company with a diverse product line is CV Sciences (CVSI). Its pipeline consists of CVSI-007, a smokeless tobacco cessation product. The drug candidate comes in the form of a chewing gum, which contains nicotine and synthetic CBD. Consumer products already on the market include PlusCBD Oil, a dietary supplement sold in capsules, sprays, balms, drops, concentrates and vape liquid in nearly 1,000 retail locations. Vape blends are sold via CVSI’s Purified Liquids store, while cannabinoids are sold wholesale to serve the growing CBD wellness market. The company recently presented at the Natural Products Expo East 2017, in Baltimore, Maryland, and the MJAC2017 InvestorsHub International Cannabis Conference in Los Angeles, California.

The international cannabis market is also experiencing considerable growth, and Medical Marijuana (MJNA) distinguishes itself as the first publicly traded cannabis company in the U.S. and the first to introduce legal medical cannabis in Brazil. Its e-commerce store sells numerous brands and categories of CBD oil, including capsules, isolates, chewing gum, vape oil, vaporizer pens and body lotions and creams. In addition to pen-type vaporizers, the company also sells portable and tabletop units, as well as an electric dabbing system for vaporizing medical concentrates. All products are sold as dietary supplements rather than medical marijuana, so they can be purchased legally without doctor recommendations.

Terra Tech (TRTC) supplies the medical cannabis market via brands such as IVXX™, a cultivator and producer of different concentrates and other products, and Edible Garden®, which uses Dutch hydroponic farming methods to produce Global Food Safety Initiative-certified products, including a wide range of herbs and leafy greens. The company therefore serves the food industry as well, but it also specializes in high-grade medical cannabis that is produced at its Blüm™ facility. In addition, Terra Tech’s MediFarm division manages the permit application and procurement process for marijuana cultivators, while GrowOp Technology designs and manufactures horticultural equipment and automation/control software.

MassRoots (MSRT) offers an extremely diverse product line via its online catalog. Searchable by plant type, flavors, effects, health conditions, and manufacturer, it gives customers one of the most simple and comprehensive sources of edibles, lotions, drops and more. The company’s website has an educational article section plus a news page with frequent updates. Another resource featured on the site is a local dispensary search function, but the company also serves other businesses, providing a connection with point-of-sale systems that enable retailers to display their inventory in real time and provide customers with simple online ordering.

Cannabis companies are serving a fast-growing and diversifying market by various means. The skincare and healthcare products and social app from ChineseInvestors.com, Inc. (CIIX) are prime examples. The products and services of the companies discussed above have become relevant in the current business climate and show potential to keep pace with broader industry growth.

For more on ChineseInvestors.com please visit: ChineseInvestors.com, Inc. (CIIX)

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.  The forward-looking statements in this release are made as of the date hereof and NNW undertake no obligation to update such statements.

Archives

Select A Month

Contact us: 212.418.1217